Memorial Sloan Kettering surgeon Danielle Bello

Danielle Bello, MD

Areas of Expertise

My Specialties

  • Melanoma
  • Merkel Cell Carcinoma
  • Squamous Cell Carcinoma

Request an Appointment

Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
English
Share

About Me

What I Do at MSK
  • Assistant Attending Surgeon
Get To Know Me

I am a surgical oncologist specializing in the care of patients with cutaneous malignancies (cancer that begins in cells that form the outer layer of the skin). These include melanoma, Merkel cell carcinoma, squamous cell carcinoma, basal cell carcinoma, and sweat gland tumors.

I see between 800 and 1,000 patients with cutaneous malignancies each year at MSK locations on Long Island, NY and in Middletown, NJ.

Read more

When patients come to me, they are often concerned about what their diagnosis means for their well-being and quality of life. I understand that a cancer diagnosis can be unnerving, and I take the time to answer patients’ questions about their disease patiently and empathetically. At Memorial Sloan Kettering Cancer Center, I work closely with colleagues across medical oncology, radiation oncology, pathology, nursing, and supportive care, who all specialize in the treatment of cutaneous malignancies. We spend time with our patients and their loved ones to understand their unique needs and wishes and ultimately, to recommend a treatment plan that is best for them.

I decided to pursue a career in oncology because I felt that this field was where I could make a difference. Most people will be affected by cancer at some point in their lives, either personally or through connection to a loved one, and this can take both a physical and an emotional toll. I wanted to be a part of their solution—not just by surgically treating their disease, but also by supporting them in their journey and individualizing their care so they get the best possible treatment for them. It is important to me that patients and their caregivers know that they are receiving personalized, state-of-the-art care and feel uplifted by our team of experts at each step in the process.

In addition to providing compassionate care to all who come to me, I am committed to bettering outcomes for patients with cutaneous malignancies through the study of different subsets of melanoma, such as acral melanoma. The less common types of melanomas are genetically distinct from the more common cutaneous melanomas. By better understanding these differences, I believe that we can improve how we care for people with these diseases.

Beyond researching these subsets, I am also investigating new ways to combine surgery with immunotherapy to boost outcomes in patients with advanced or melanoma that has metastasized or spread to other parts of the body. I am currently involved in studies aimed at defining the role of injecting highly concentrated drugs directly into skin lesions for patients with metastatic disease to improve their outcomes.

I enjoy spending time with my husband and three children and traveling together when we can.

My Role at MSK

A surgeon is a doctor with special training in many kinds of surgery.

Areas of Expertise

My Specialties

  • Melanoma
  • Merkel Cell Carcinoma
  • Squamous Cell Carcinoma
  • Basal Cell Carcinomas
  • Sweat Gland Tumors
Education & Honors

Education

  • MD, Mount Sinai School of Medicine

Residencies

  • Surgery – Yale University School of Medicine

Awards and Honors

  • David and Monica Gorin Award of Courage Fellow, Memorial Sloan Kettering Cancer Center (2017-2018)

Fellowships

  • Surgical Oncology – Memorial Sloan Kettering Cancer Center

Board Certifications

  • General Surgery, Surgical Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA retirees only)

In Network Coverage Type
PPO

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

Blue Cross Blue Shield New York

In Network Coverage Type
PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

Blue Cross Health Plus

In Network Coverage Type
HMO

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

MSK has a tentative agreement with Cigna to continue coverage in 2024.

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage

In Network Coverage Type
PPO, HMO

Empire Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

Fidelis

In Network Coverage Type
HMO, EPO

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients

Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Bello sees patients at three locations.

Office Phone
Location
Commack, NY
Middletown, NJ
Uniondale, NY
480 Red Hill Road Middletown NJ 07748
1101 Hempstead Turnpike Uniondale NY 11553

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Gastric and Mixed Tumor Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Kurtansky NR, Manci RN, Bello DM, Adamson AS, Shoushtari AN, Wehner MR, Ariyan CE, Marghoob AA, Marchetti MA, Rotemberg V. Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma. Br J Dermatol. 2022 Mar 23. doi: 10.1111/bjd.21251. Online ahead of print. PMID: 35318644 No abstract available.

Thomas D, Bello DM. Adjuvant immunotherapy for melanoma. J Surg Oncol. 2021 Mar;123(3):789-797.

Sahu, A, Oh, Y, Peterson G. Cordova M, Navarrete-Dechent C, Gill M, Alessi-Fox C, Gonzalez S, Phillips W, Wilson S, Afzalneia R, Rose R, Mohsen A, Bello D, Marghoob A, Rossi A, Wolchok JD, Merghoub T, Rotemberg V, Chen CSJ, Rajadhyaksha M In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathology. Sci Rep. 2021 Nov 30;11(1):23124.

Read more

Bello DM, Faries MB. The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes). Ann Surg Oncol. 2020 Jan;27(1):15-21.

Bello DM, Ariyan CE. ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era? Ann Surg Oncol. 2020 Jan 17.

Bello DM. Indications for the surgical resection of stage IV disease. J Surg Oncol. 2019

Bello DM, Panageas KS, Hollmann TJ, Shoushtari AN, Chapman P, Postow MA, Callahan MK, Wolchok JD, Brady MS, Coit D, Ariyan CE. Outcomes of Patients with Metastatic Melanoma Selected for Surgery After Immunotherapy. Plenary presentation at the 71st Annual Meeting of the Society of Surgical Oncology, March 21-24, 2018, Chicago, IL.

Bello DM, Ariyan CE. Adjuvant Therapy in the Treatment of Melanoma. Ann Surg Oncol. 2018 Jul;25(7):1807-1813.

Bello DM, Panageas KS, Hollmann T, Shoushtari AN, Momtaz P, Chapman PB, Postow MA, Callahan MK, Wolchok JD, Brady MS, Coit DG, Ariyan CE. Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade. Ann Surg Oncol. 2019 Dec 17.

Bello DM, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Ann Surg Oncol. 2016 Dec;23(Suppl 5):938-945.

Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25.

Publications on PubMed

Visit PubMed for a full listing of Dr. Bello’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Danielle Bello discloses the following relationships and financial interests:

  • Office Hours
    Professional Services and Activities
  • Philogen S.p.A.
    Professional Services and Activities (Uncompensated)

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures